查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
单细胞分析的全球市场：按细胞类型、副产品、按技术、按应用□最终用户,按地区预测（截至 2028 年）
市场调查报告书
商品编码
1298017

单细胞分析的全球市场：按细胞类型、副产品、按技术、按应用□最终用户,按地区预测（截至 2028 年）

Single cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 332 Pages | 订单完成后即时交付

价格
简介目录

全球单细胞分析市场规模预计将从2023年的35亿美元增长到2028年的71亿美元，预测期内復合年增长率为15.3%。 新型和先进的单细胞分析技术（微流体、基于液滴的方法、高通量测序平台等）的发展正在推动市场增长。

此外，对个性化医疗的日益关注以及政府和私人组织对生命科学和生物技术研究的投资正在推动对单细胞分析产品和技术的需求。

“在预测期内（2023-2028 年）消耗品领域将以最高复合年增长率增长”

按产品划分，消耗品领域预计在预测期内将以最高复合年增长率增长。这种增长是由于细胞研究中消耗品的需求增加所致。高通量单细胞分析技术，例如基于液滴的方法和微流控技术，需要微流控芯片、试剂和微珠等消耗品来实现高效的细胞捕获、条形码和处理。随着这些技术变得越来越流行，并且研究人员寻求同时分析更多的单细胞，对耗材的需求也在增加。样品製备是单细胞分析的关键步骤，耗材在细胞分离、裂解和核酸提取中发挥着重要作用。高效可靠的单细胞分离和製备需要细胞分离试剂、提取试剂盒和反应管等消耗品，有助于消耗品领域的增长。预先优化的试剂盒、板和管等消耗品有助于简化和标准化实验工作流程，提高效率并减少单细胞分析的变异性。研究人员更喜欢专门为单细胞应用设计的耗材，以确保结果一致和准确。

“2023年人体细胞领域将占据压倒性的市场份额”

按细胞类型划分，由于人们对人类疾病研究的兴趣日益浓厚，预计人类细胞部分将在预测期内占据主导份额。了解人体组织和器官内的细胞异质性对于增进我们对各种疾病的理解和开发靶向治疗至关重要。单细胞分析使研究人员能够研究人体组织内单个细胞之间的遗传、表观遗传和表型差异，从而更深入地了解疾病机制。因此，对人体细胞的单细胞分析的需求不断增加。

“下一代测序领域在预测期内（2023-2028 年）将以最高复合年增长率增长”

从技术角度来看，下一代测序（NGS）领域预计在预测期内将以最高的复合年增长率增长。这种增长归因于高通量测序能力，该能力使研究人员能够同时分析数千个单个细胞的遗传物质。

“研究应用领域将在 2022 年占据市场份额”

按应用来看单细胞分析市场，研究应用（癌症研究、免疫学研究、神经学研究、干细胞研究、组织再生、病毒、药物发现和其他（衰老研究等））是主导部分。占有份额。单细胞分析通过提供对细胞功能和相互作用的前所未有的洞察而彻底改变了基础生物学研究。这使得研究人员能够发现新的细胞类型、识别稀有细胞群并绘製细胞谱系图。

“在预测期内（2023-2028年），学术和研究机构部门将以最高复合年增长率增长”

从最终用户来看，学术和研究机构细分市场在预测期内将以最高的复合年增长率增长。研究重点的增加是预测市场增长的主要因素之一。

“亚太地区：更快增长的可能性”

按地区划分，北美将在 2022 年占据市场主导地位。该地区的优势源于多种因素，包括该地区大公司的存在和技术进步。另一方面，由于人口增长和政府改善医疗设施和基础设施等多种因素，亚太地区可能会以更快的速度增长。

目录

第 1 章 简介

第二章研究方法论

第三章执行摘要

第 4 章重要注意事项

第五章市场概况

  • 介绍
  • 市场动态
    • 促进者
    • 抑製剂
    • 机会
    • 任务
  • 影响客户业务的趋势/中断
  • 参考价格分析
  • 价值链分析
  • 供应链分析
  • 生态系统分析
  • 监管分析
  • 波特五力分析
  • 主要会议和活动（2023-2024）
  • 技术分析
  • 主要利益相关者和采购标准
  • 专利分析

6. 单细胞分析市场（分产品）

  • 介绍
  • 消耗品
    • 珠子
    • 微孔板
    • 试剂
    • 检测试剂盒
    • 其他耗材
  • 设备
    • 流式细胞仪
    • NGS系统
    • PCR仪
    • 分光光度计
    • 细胞计数器
    • 显微镜
    • HCS系统
    • 微阵列
    • 其他设备

7. 单细胞分析市场（按细胞类型）

  • 介绍
  • 人体细胞
  • 动物细胞
  • 微生物细胞

8. 单细胞分析市场（按技术）

  • 介绍
  • 流式细胞仪
  • 新一代测序 (NGS)
  • 聚合□炼式反应 (PCR)
  • 显微镜
  • 质谱（MS）
  • 其他技术

9 单细胞分析市场（按应用）

  • 介绍
  • 研究用途
    • 癌症研究
    • 免疫学研究
    • 神经学研究
    • 干细胞研究
    • 其他研究用途
  • 医疗用途
    • 无创产前诊断
    • 体外受精
    • 循环肿瘤细胞的检测

10 单细胞分析市场，按最终用户划分

  • 介绍
  • 学术/研究机构
  • 生物技术和製药公司
  • 医院/诊断实验室
  • 细胞库/体外受精中心

11 单细胞分析市场（按地区）

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 拉丁美洲
  • 中东/非洲

第十二章 竞争格局

  • 介绍
  • 市场参与者采取的关键策略
  • 收入分析
  • 市场份额分析
  • 企业评级象限：领先企业
  • 企业评级象限：针对初创企业/中小企业
  • 竞争标桿
  • 竞争场景和趋势

第十三章公司简介

  • 大公司
    • BECTON, DICKINSON AND COMPANY
    • DANAHER CORPORATION
    • MERCK KGAA
    • THERMO FISHER SCIENTIFIC, INC.
    • QIAGEN N.V.
    • 10X GENOMICS
    • ILLUMINA, INC.
    • BIO-RAD LABORATORIES
    • PROMEGA CORPORATION
    • STANDARD BIOTOOLS
    • AGILENT TECHNOLOGIES, INC.
    • CORNING INCORPORATED
    • TAKARA BIO INC.
    • BIOMERIEUX SA
    • TECAN GROUP LTD.
    • SARTORIUS AG
    • DIASORIN S.P.A.
  • 其他公司
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • CYTEK BIOSCIENCES
    • FLUXION BIOSCIENCES INC.
    • MENARINI SILICON BIOSYSTEMS
    • APOGEE FLOW SYSTEMS LTD.
    • NANOCELLECT BIOMEDICAL
    • ON-CHIP BIOTECHNOLOGIES CO., LTD.
    • RARECYTE, INC.

第十四章附录

简介目录
Product Code: BT 4224

The global single-cell analysis market size is projected to reach USD 7.1 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period. The development of new and advanced single-cell analysis technologies, such microfluidics, droplet-based methods, and high-throughput sequencing platforms, is driving the growth of the market. Additionally, the increasing focus on personalized medicine, governments and private organizations' investments in life sciences and biotechnology research are driving the demand for single-cell analysis products and technologies.

"The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of product, the single-cell analysis market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. High-throughput single-cell analysis technologies, such as droplet-based methods and microfluidics, require consumables like microfluidic chips, reagents, and beads for efficient cell capture, barcoding, and processing. As these technologies gain popularity and researchers seek to analyze larger numbers of single cells simultaneously, the demand for consumables increases. Sample preparation is a critical step in single-cell analysis, and consumables play a crucial role in cell isolation, lysis, and extraction of nucleic acids. Consumables such as cell separation reagents, extraction kits, and reaction tubes are necessary for efficient and reliable single-cell isolation and preparation, contributing to the growth of the consumables segment. Consumables, including pre-optimized kits, plates, and tubes, help streamline and standardize the experimental workflow, improving efficiency and reducing variability in single-cell analysis. Researchers often prefer consumables specifically designed for single-cell applications to ensure consistent and accurate results.

"The human cells segment is expected to hold a dominant share in 2023."

Based on the cell type, the market is segmented into human cells, animal cells and microbial cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing interest in human diseases research. Understanding the cellular heterogeneity within human tissues and organs is crucial for advancing our understanding of various diseases and developing targeted therapies. Single-cell analysis allows researchers to study the genetic, epigenetic, and phenotypic differences between individual cells within human tissues, enabling a deeper understanding of disease mechanisms. This has led to increased demand for single-cell analysis of human cells.

"The next-generation sequencing segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. The next-generation sequencing segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to its high-throughput sequencing capabilities, allowing researchers to analyze the genetic material of thousands of individual cells simultaneously.

"In 2022, the research applications segment held a dominant share."

Based on application, the single-cell analysis market is segmented into research applications, and medical applications. The research applications segment held a dominant share of the single-cell analysis market. The research applications of single-cell analysis include cancer research, immunology research, neurology research, stem cell research, and other research applications such as tissue regeneration, virology, drug discovery, and research on aging. Single-cell analysis has revolutionized basic biological research by providing unprecedented insights into cellular functions and interactions. It enables researchers to discover new cell types, identify rare cell populations, and map cell lineages.

"The academic & research laboratories segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

Based on end user, the single-cell analysis market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment to grow at the highest CAGR during the forecast period. Increasing imphasis on research is one of the major factors anticipated to project market growth.

"Asia Pacific region is likely to grow at faster pace."

The single-cell analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of single-cell analysis market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80%, and Demand Side - 20%
  • By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
  • By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Becton, Dickinson and Company (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific, Inc. (US)
  • 10x Genomics (US)
  • Promega Corporation (US)
  • Illumina, Inc. (US)
  • Bio-Rad Laboratories (US)
  • Standard BioTools (US)
  • Agilent Technologies, Inc. (US)
  • Tecan Group Ltd. (Switzerland)
  • Sartorius AG (Germany)
  • DiaSorin S.p.A. (Italy)
  • Takara Bio, Inc. (Japan)
  • Fluxion Biosciences (US)
  • Menarini Silicon Biosystems Inc. (Italy)
  • bioMerieux SA (France)
  • Oxford Nanopore Technologies (UK)
  • Cytek Biosciences (US)
  • Corning Incorporated (US)
  • Apogee Flow Systems Ltd. (UK)
  • NanoCellect Biomedical (US)
  • RareCyte, Inc. (US)
  • On-chip Biotechnologies Co., Ltd. (Japan).

Research Coverage:

This report provides a detailed picture of the single-cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Technological advancements in single-cell analysis products, rising prevalence of cancer, increasing R&D in the pharmaceutical & biotechnology industries, growth in stem cell research, growing focus on personalized medicine), restraints (High cost of single-cell analysis products), opportunities (High growth potential of single-cell sequencing (SCS), integration of microfluidics in single-cell analysis, emerging Asian markets) and challenges (Standardization of Protocols and Data Integration and Quality Control to developing cell therapies) influencing the growth of single-cell analysis market.
  • Product Development/Innovation: Detailed insights on newly launched products, and technological assessment of the single-cell analysis market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the single-cell analysis market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players in the single-cell analysis market. The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 SINGLE-CELL ANALYSIS MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 SINGLE-CELL ANALYSIS MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 INSIGHTS ON SINGLE-CELL ANALYSIS MARKET FROM PRIMARY EXPERTS
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 7 MARKET GROWTH RATE PROJECTION, 2023-2028
    • FIGURE 8 SINGLE-CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET

4 PREMIUM INSIGHTS

  • 4.1 SINGLE-CELL ANALYSIS MARKET OVERVIEW
    • FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SHARE, BY PRODUCT & COUNTRY (2022)
    • FIGURE 17 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2022
  • 4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 CONSUMABLES WILL CONTINUE TO DOMINATE SINGLE-CELL ANALYSIS MARKET IN 2028
  • 4.4 SINGLE-CELL ANALYSIS MARKET SHARE, BY END USER, 2023 VS. 2028
    • FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023
  • 4.5 SINGLE-CELL ANALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES
    • FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN SINGLE-CELL ANALYSIS MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological advancements in single-cell analysis products
    • TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
      • 5.2.1.2 Rising prevalence of cancer
    • TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
      • 5.2.1.3 Increasing R&D in pharmaceutical & biotechnology industries for complex diseases
    • FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014-2028
      • 5.2.1.4 Growth in stem cell research
      • 5.2.1.5 Growing focus on personalized medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of single-cell analysis products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth potential of single-cell sequencing
      • 5.2.3.2 Integration of microfluidics in single-cell analysis
      • 5.2.3.3 Emerging Asian markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS
  • 5.4 INDICATIVE PRICING ANALYSIS
    • TABLE 5 AVERAGE PRICE RANGE OF SINGLE-CELL ANALYSIS PRODUCTS (2022)
    • TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2022)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 24 MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 25 SUPPLY CHAIN ANALYSIS OF SINGLE-CELL ANALYSIS MARKET
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 26 ECOSYSTEM ANALYSIS: SINGLE-CELL ANALYSIS MARKET
    • TABLE 7 SINGLE-CELL ANALYSIS MARKET ECOSYSTEM
  • 5.8 REGULATORY ANALYSIS
    • TABLE 8 REGULATORY SCENARIO
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 9 SINGLE-CELL ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 10 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.11 TECHNOLOGY ANALYSIS
    • TABLE 11 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
    • FIGURE 28 KEY BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS
  • 5.13 PATENT ANALYSIS
    • FIGURE 29 PATENTS GRANTED IN SINGLE-CELL ANALYSIS MARKET OVER LAST 10 YEARS
    • TABLE 12 INDICATIVE LIST OF PATENTS IN SINGLE-CELL ANALYSIS MARKET

6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 13 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 14 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 15 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 BEADS
      • 6.2.1.1 Wide application of beads in isolation of RNA and DNA to drive market
    • TABLE 17 SINGLE-CELL ANALYSIS BEADS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 18 SINGLE-CELL ANALYSIS BEADS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 MICROPLATES
      • 6.2.2.1 Increasing demand for genomic technologies to boost market
    • TABLE 19 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 REAGENTS
      • 6.2.3.1 Advancements in single-cell genomics to increase adoption of reagents
    • TABLE 21 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 22 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 ASSAY KITS
    • TABLE 23 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 24 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 25 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.4.1 Immunoassays
        • 6.2.4.1.1 Innovations in immunoassays to drive growth
    • TABLE 26 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.4.2 Cell-based assays
        • 6.2.4.2.1 Rising R&D activities in pharma and biopharma companies to drive demand
    • TABLE 28 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 OTHER CONSUMABLES
    • TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 32 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 33 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 FLOW CYTOMETERS
      • 6.3.1.1 Technological advancements in flow cytometry to drive market
    • TABLE 35 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 NGS SYSTEMS
      • 6.3.2.1 Advancements in NGS systems to support market growth
    • TABLE 37 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 PCR INSTRUMENTS
      • 6.3.3.1 Use of PCR to amplify DNA and mRNA from single cells to study gene expression to boost market growth
    • TABLE 39 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 SPECTROPHOTOMETERS
      • 6.3.4.1 Significant technological advancements to favor market growth
    • TABLE 41 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 42 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.5 CELL COUNTERS
      • 6.3.5.1 Reliable and quick results to support adoption
    • TABLE 43 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.6 MICROSCOPES
      • 6.3.6.1 Wide applications in cell-based research to drive adoption
    • TABLE 45 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 46 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.7 HCS SYSTEMS
      • 6.3.7.1 Increasing need for multi-parametric cell analysis to drive adoption
    • TABLE 47 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 48 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.8 MICROARRAYS
      • 6.3.8.1 Increasing demand in molecular biology to support market growth
    • TABLE 49 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 50 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.9 OTHER INSTRUMENTS
    • TABLE 51 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)

7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE

  • 7.1 INTRODUCTION
    • TABLE 53 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
  • 7.2 HUMAN CELLS
    • 7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET
    • TABLE 54 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 ANIMAL CELLS
    • 7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
    • TABLE 56 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 MICROBIAL CELLS
    • 7.4.1 RISING GOVERNMENT SUPPORT TO DETECT AND COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
    • TABLE 58 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)

8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE

  • 8.1 INTRODUCTION
    • TABLE 60 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 8.2 FLOW CYTOMETRY
    • 8.2.1 WIDE USAGE TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
    • TABLE 61 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 NEXT-GENERATION SEQUENCING
    • 8.3.1 ADVANTAGES SUCH AS EFFECTIVE SCREENING AND MANAGEMENT OF HIGH-VOLUME DATA TO BOOST ADOPTION
    • TABLE 63 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 64 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 POLYMERASE CHAIN REACTION
    • 8.4.1 ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH
    • TABLE 65 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 66 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 MICROSCOPY
    • 8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET
    • TABLE 67 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 68 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 MASS SPECTROMETRY
    • 8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
    • TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 70 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.7 OTHER TECHNIQUES
    • TABLE 71 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 72 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021-2028 (USD MILLION)

9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 73 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 RESEARCH APPLICATIONS
    • TABLE 74 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.1 CANCER RESEARCH
      • 9.2.1.1 Growing prevalence of cancer to support market growth
    • TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.2 IMMUNOLOGY RESEARCH
      • 9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market
    • TABLE 79 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 80 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.3 NEUROLOGY RESEARCH
      • 9.2.3.1 Increasing incidence of neurological disorders to propel market
    • TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.4 STEM CELL RESEARCH
      • 9.2.4.1 Rising investments in stem cell research to drive market
    • TABLE 83 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.2.5 OTHER RESEARCH APPLICATIONS
    • TABLE 85 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 MEDICAL APPLICATIONS
    • TABLE 87 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.3.1 NONINVASIVE PRENATAL DIAGNOSIS
      • 9.3.1.1 Rising prevalence of genetic diseases to drive market
    • TABLE 90 SINGLE-CELL ANALYSIS MARKET FOR NONINVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR NON INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.3.2 IN VITRO FERTILIZATION
      • 9.3.2.1 Increasing demand for IVF procedures to support market growth
    • TABLE 92 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 93 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • 9.3.3 CIRCULATING TUMOR CELL DETECTION
      • 9.3.3.1 Rising prevalence of cancer to drive market
    • TABLE 94 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 95 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOUR CELL DETECTION, BY COUNTRY, 2021-2028 (USD MILLION)

10 SINGLE-CELL ANALYSIS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 96 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 ACADEMIC & RESEARCH LABORATORIES
    • 10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
    • TABLE 97 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
    • 10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH
    • TABLE 99 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 100 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE ADOPTION
    • TABLE 101 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 102 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 CELL BANKS & IVF CENTERS
    • 10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH
    • TABLE 103 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 104 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)

11 SINGLE-CELL ANALYSIS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 106 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 108 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Increasing R&D investments and funding to drive market
    • FIGURE 31 NIH FUNDING FOR STEM CELL RESEARCH (2011-2021)
    • TABLE 117 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 US: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 122 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 123 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 124 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 High prevalence of hemophilia to drive market
    • TABLE 127 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 CANADA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 133 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 134 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 136 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.3 NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    • TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 138 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 139 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 145 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Government support for research funding to propel market
    • TABLE 148 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 149 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 GERMANY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 151 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 154 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 155 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 157 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Favorable research conditions to support market growth
    • TABLE 158 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 159 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 UK: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 164 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 High burden of cancer to propel market
    • TABLE 168 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 169 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 FRANCE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 172 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 173 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 174 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 175 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Increasing cell biology seminars and conferences to drive market
    • TABLE 178 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 179 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 ITALY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 181 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 183 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 184 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 185 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to drive market
    • TABLE 188 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 189 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 190 SPAIN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 193 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 194 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 195 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 196 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 198 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 199 REST OF EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 200 REST OF EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 201 REST OF EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 202 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 203 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 204 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 205 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 206 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.7 EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
    • TABLE 208 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 Government initiatives to promote stem cell research to propel market
    • TABLE 219 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 220 CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 221 CHINA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 223 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 224 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 225 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 226 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 227 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Rising geriatric population and growing focus on personalized medicine to drive market
    • TABLE 229 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
    • TABLE 230 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 231 JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 JAPAN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 233 JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 234 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 235 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 236 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 237 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 238 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 239 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Expansion of pharmaceutical and biotechnology industries to support market growth
    • TABLE 240 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 241 INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 242 INDIA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 243 INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 244 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 245 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 246 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 247 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.4 REST OF ASIA PACIFIC
    • TABLE 250 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 251 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 252 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 253 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 255 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 256 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 257 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 258 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 259 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.5 ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    • 11.5.1 EXPANSION OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET
    • 11.5.2 LATIN AMERICA: RECESSION IMPACT
    • TABLE 260 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 261 LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 263 LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 264 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 265 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 266 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 267 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 268 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES TO DRIVE MARKET
    • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 270 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 271 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 272 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 273 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 274 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 275 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 276 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 277 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 279 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS
    • FIGURE 33 SINGLE-CELL ANALYSIS MARKET: STRATEGIES ADOPTED
  • 12.3 REVENUE ANALYSIS
    • FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES, 2020-2022
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 35 SINGLE-CELL ANALYSIS MARKET SHARE, BY KEY PLAYER (2022)
    • TABLE 280 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
  • 12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 36 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS, 2022
  • 12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 STARTING BLOCKS
    • 12.6.3 RESPONSIVE COMPANIES
    • 12.6.4 DYNAMIC COMPANIES
    • FIGURE 37 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • 12.7 COMPETITIVE BENCHMARKING
    • 12.7.1 COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
    • TABLE 281 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 12.7.2 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
    • TABLE 282 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET
    • 12.7.3 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
    • TABLE 283 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET
  • 12.8 COMPETITIVE SCENARIO AND TRENDS
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 284 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
    • 12.8.2 DEALS
    • TABLE 285 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2020-MAY 2023
    • 12.8.3 EXPANSIONS
    • TABLE 286 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2020-MAY 2023

13 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 13.1 KEY COMPANIES
    • 13.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 13.1.2 DANAHER CORPORATION
    • TABLE 288 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.3 MERCK KGAA
    • TABLE 289 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 13.1.4 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 290 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
    • FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 13.1.5 QIAGEN N.V.
    • TABLE 291 QIAGEN N.V.: COMPANY OVERVIEW
    • FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
    • 13.1.6 10X GENOMICS
    • TABLE 292 10X GENOMICS: COMPANY OVERVIEW
    • FIGURE 43 10X GENOMICS: COMPANY SNAPSHOT (2022)
    • 13.1.7 ILLUMINA, INC.
    • TABLE 293 ILLUMINA, INC.: COMPANY OVERVIEW
    • FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.8 BIO-RAD LABORATORIES
    • TABLE 294 BIO-RAD LABORATORIES: COMPANY OVERVIEW
    • FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2022)
    • 13.1.9 PROMEGA CORPORATION
    • TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 13.1.10 STANDARD BIOTOOLS
    • TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
    • FIGURE 46 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
    • 13.1.11 AGILENT TECHNOLOGIES, INC.
    • TABLE 297 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.12 CORNING INCORPORATED
    • TABLE 298 CORNING INCORPORATED: COMPANY OVERVIEW
    • FIGURE 48 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
    • 13.1.13 TAKARA BIO INC.
    • TABLE 299 TAKARA BIO INC.: COMPANY OVERVIEW
    • FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
    • 13.1.14 BIOMERIEUX SA
    • TABLE 300 BIOMERIEUX SA.: COMPANY OVERVIEW
    • FIGURE 50 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
    • 13.1.15 TECAN GROUP LTD.
    • TABLE 301 TECAN GROUP LTD.: COMPANY OVERVIEW
    • FIGURE 51 TECAN GROUP LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.16 SARTORIUS AG
    • TABLE 302 SARTORIUS AG: COMPANY OVERVIEW
    • FIGURE 52 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 13.1.17 DIASORIN S.P.A.
    • TABLE 303 DIASORIN S.P.A.: COMPANY OVERVIEW
    • FIGURE 53 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022)
  • 13.2 OTHER PLAYERS
    • 13.2.1 OXFORD NANOPORE TECHNOLOGIES PLC
    • 13.2.2 CYTEK BIOSCIENCES
    • 13.2.3 FLUXION BIOSCIENCES INC.
    • 13.2.4 MENARINI SILICON BIOSYSTEMS
    • 13.2.5 APOGEE FLOW SYSTEMS LTD.
    • 13.2.6 NANOCELLECT BIOMEDICAL
    • 13.2.7 ON-CHIP BIOTECHNOLOGIES CO., LTD.
    • 13.2.8 RARECYTE, INC.
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS